Inequities in cancer care and outcomes
Washington Post Live
00:00
The Importance of Diversity in Clinical Trials
Less than 5% of oncology clinical trial participants are black. Trial eligibility criteria that disproportionately exclude people of color. Lack of representation in trials also affects our ability to examine whether drugs are effective and safe across different populations.
Transcript
Play full episode
